HIV-associated lymphoma—advances in clinical management
J Khwaja, JE Burns, N Ahmed… - Annals of Lymphoma, 2021 - discovery.ucl.ac.uk
The association between human immunodeficiency virus (HIV) and lymphoma was
observed early in the HIV epidemic in the 1980s. Lymphoma incidence remains significantly …
observed early in the HIV epidemic in the 1980s. Lymphoma incidence remains significantly …
Outcome of limited‐stage peripheral T‐Cell lymphoma after CHOP (− like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology …
A Ludvigsen Al‐Mashhadi, H Cederleuf… - American Journal of …, 2023 - Wiley Online Library
Abstract Peripheral T‐Cell Lymphomas (PTCLs) are rare, aggressive lymphomas with poor
outcomes, but limited‐stage disease is infrequent and not well‐described. This study reports …
outcomes, but limited‐stage disease is infrequent and not well‐described. This study reports …
Why R-CHOP+ X is not enough: lessons learned and next steps in the mission to improve frontline therapy for diffuse large B-cell lymphoma
HJJ Cherng, J Westin - Leukemia & lymphoma, 2021 - Taylor & Francis
Two-thirds of newly diagnosed cases of diffuse large B-cell lymphoma (DLBCL) are cured
with R-CHOP, an immunochemotherapy regimen that has been the standard of care for …
with R-CHOP, an immunochemotherapy regimen that has been the standard of care for …
What factors are associated with the prognosis of primary testicular diffuse large B-cell lymphoma? A study based on the SEER database
S Yang, W Chang, B Zhang, P Shang - Journal of Cancer Research and …, 2023 - Springer
Purpose Primary testicular diffuse large B-cell lymphoma (PT-DLBCL) is a relatively rare
urological tumor with a high degree of malignancy and a poor prognosis. This study aimed …
urological tumor with a high degree of malignancy and a poor prognosis. This study aimed …
B-cell non-Hodgkin lymphomas
E Silkenstedt, G Salles, E Campo, M Dreyling - The Lancet, 2024 - thelancet.com
B-cell lymphomas occur with an incidence of 20 new cases per 100 000 people per year in
high-income countries. They can affect any organ and are characterised by heterogeneous …
high-income countries. They can affect any organ and are characterised by heterogeneous …
Balancing the therapeutic ratio in DLBCL requires appropriate, individualized patient selection rather than broad elimination of radiation therapy
BA Campbell, RL Bakst, SA Milgrom… - International Journal of …, 2022 - redjournal.org
In 2005, the Lymphoma Study Association/Groupe Ouest-Est des Leucémies et des Autres
Maladies du Sang (LYSA/GOELAMS) groups initiated this randomized study addressing the …
Maladies du Sang (LYSA/GOELAMS) groups initiated this randomized study addressing the …
New standards of care for treatment of diffuse large B‐cell lymphoma
C Abeyakoon, GP Gregory - British Journal of Haematology, 2024 - Wiley Online Library
Treatment of newly diagnosed diffuse large B‐cell lymphoma with rituximab and CHOP (R‐
CHOP) has been largely unchanged for the last two decades. The Guideline by Fox et al …
CHOP) has been largely unchanged for the last two decades. The Guideline by Fox et al …
[HTML][HTML] Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis
Rituximab has improved response rates and overall survival in diffuse large B-cell
lymphoma. Radiotherapy is an effective treatment modality for lymphomas, but there is …
lymphoma. Radiotherapy is an effective treatment modality for lymphomas, but there is …
[HTML][HTML] Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for intermediate and high risk diffuse large B-cell …
J Wang, X Liu, Y Wu, Q Zhong, T Wu, Y Yang… - Journal of the National …, 2024 - Elsevier
Objective To evaluate whether improved progression-free survival (PFS) from radiotherapy
(RT) translates into an overall survival (OS) benefit for diffuse large B-cell lymphoma …
(RT) translates into an overall survival (OS) benefit for diffuse large B-cell lymphoma …
Independent predictors of mortality and 5-year trends in mortality and resource utilization in hospitalized patients with diffuse large B cell lymphoma
Background This retrospective study analyzed factors influencing all-cause inpatient
mortality in 80,930 adult patients (2016–2020) with diffuse large B cell lymphoma using the …
mortality in 80,930 adult patients (2016–2020) with diffuse large B cell lymphoma using the …